MedPath

Validity and reliability study of the Japanese version of EORTC QLQ-OH17

Not Applicable
Conditions
Malignancy
Registration Number
JPRN-UMIN000014277
Lead Sponsor
Japanese Organisation for Research and Treatment of Cancer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe cognitive impairments

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The psychometric properties, including criterion validity, construct validity, multi-trait scaling analysis, internal consistency, test-retest reliability, sensitivity, were assessed.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath